BioCentury
ARTICLE | Politics & Policy

FDA seeking input on ALS

January 31, 2013 2:08 AM UTC

FDA will hold a public hearing on Feb. 25 to obtain stakeholder input on the needs and preferences of amyotrophic lateral sclerosis patients, as well as input on how to be responsive to those needs. The agency is seeking input on the way it regulates the scientific evaluation, marketing authorization and postmarketing surveillance of potential products to diagnose or treat ALS. Comments are due March 25. ...